glp 1 agonist constipation GLP-1 GLP-1 Gut Side Effects: Bloating

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

See if you qualify

Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence